ClinicalTrials.Veeva

Menu

Multi-center Research Project for Glioma Molecular Pathology Intraoperative Rapid Detection

J

Jinsong Wu

Status

Completed

Conditions

Glioma, Malignant

Treatments

Diagnostic Test: Intraoperative Rapid Detection mutation of IDH, TERT and BRAF v600e

Study type

Observational

Funder types

Other

Identifiers

NCT04904419
KY2020-1298

Details and patient eligibility

About

We explores the accuracy and sensitivity of rapid intraoperative detection of IDH, TERT, BRAF indicators through a prospective clinical multi-center study. This part includes a total of 300 fresh tissue samples, paired blood samples, relevant clinical information and follow-up information from 300 patients with different grades of adult glioma. By comparing with the postoperative sequencing results, the specificity and sensitivity of intraoperative IDH and TERT rapid detection results are clear.

Enrollment

137 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

    1. Glioma patients with Informed Consent Form 2. Glioma patients with intact clinical information

Exclusion criteria

    1. Glioma patients without Informed Consent Form 2. Glioma patients without intact clinical information

Trial contacts and locations

4

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems